eFFECTOR Therapeutics, Inc. EFTR
Set alert
0.00 USD 0.00 0.00%
At close · Nov 2
0.0002 Day range 0.0002
0.0002 52-week range 0.01
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0002
- Prev close
- 0.0002
- Mkt cap
- 940
- Vol
- 331
- Avg vol
- 1.93K
- EPS
- -12.78
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0002
- High
- 0.0002
- Forward P/E
- -0.02
- Beta
- 0.62
- Short ratio
- 0.97
- Inst. own
- 23.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.697539
- 200-d avg
- 7.74
- 1y target
- 10.00
6M chart
Signals (53)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| RSI: Overbought | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| RSI: Overbought | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
Newest 20 of 53.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.00
Ratings (-1m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.02 | -2.02 – -2.02 | -4.25 | +52.5% | 0 | 0.0% | 1 |
| Next quarter | -1.95 | -1.95 – -1.95 | -3.25 | +40.0% | 0 | 0.0% | 1 |
| Current year | -6.17 | -6.17 – -6.17 | -16.37 | +62.3% | 0 | 0.0% | 1 |
| Next year | -2.25 | -2.25 – -2.25 | -6.17 | +63.5% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 23, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| May 25, 2023 | Stifel | Upgrade | Hold | Buy |
| May 9, 2023 | Credit Suisse | Maintained | — | Outperform |
| Mar 8, 2023 | Credit Suisse | Maintained | — | Outperform |
| Jan 8, 2023 | JMP Securities | Maintained | — | Market Outperform |
| Jan 5, 2023 | Credit Suisse | Maintained | — | Outperform |
| Nov 16, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Aug 10, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Mar 16, 2022 | Credit Suisse | Maintained | — | Outperform |
| Jan 24, 2022 | Credit Suisse | Maintained | — | Outperform |
| Jan 24, 2022 | Stifel | Downgrade | Buy | Hold |
| Jan 24, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Nov 8, 2021 | Stifel | Upgrade | Hold | Buy |
| Oct 11, 2021 | Credit Suisse | Initiated | — | Outperform |
| Oct 3, 2021 | Mizuho | Initiated | — | Buy |
| Sep 20, 2021 | JMP Securities | Initiated | — | Market Outperform |
| Sep 19, 2021 | Stifel | Initiated | — | Hold |
| Sep 12, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |